Product Information
BENAZEPRIL HCL 5 MG TABLET is a generic product labeled by AvPAK, priced at $0.0484 per EA under NDC 50268010915. Its NADAC has been published 464 times since Nov 15, 2017.
FDA first approved this application on Feb 3, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
AvPAKNDC
50268010915
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BENAZEPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076820FDA Approved
2/3/2006
TE Code
AB
On Market Since
4/28/2014
Pharmacological Classes
Price Statistics
The NADAC for BENAZEPRIL HCL 5 MG TABLET has been published 464 times since Nov 15, 2017, and over the history we have for it it has risen 14.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0484 per EA |
|---|---|
| All-time high | $0.0661 (Nov 16, 2022) |
| All-time low | $0.0272 (Nov 20, 2024) |
| 52-week high | $0.0513 |
| 52-week low | $0.0459 |
| Median price | $0.0534 |
| Average price | $0.0517 |
| Largest weekly change | +58.6% (Jun 19, 2024) |
| Weeks tracked | 464 |
| Tracking since | Nov 15, 2017 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AvPAK manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Benazepril Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BENAZEPRIL HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BENAZEPRIL HCL 5 MG TABLET, manufactured by AvPAK, is $0.0484 per EA (NDC 50268010915), effective Sep 30, 2026.
How has the price of BENAZEPRIL HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BENAZEPRIL HCL 5 MG TABLET has risen 14.9%. It has been tracked across 464 weekly CMS publications since Nov 15, 2017.
What are the highest and lowest recorded NADAC prices for BENAZEPRIL HCL 5 MG TABLET?
Since Nov 15, 2017, the NADAC for BENAZEPRIL HCL 5 MG TABLET has ranged from a low of $0.0272 (Nov 20, 2024) to a high of $0.0661 (Nov 16, 2022), with a median of $0.0534 per EA.
Are there cheaper alternatives to BENAZEPRIL HCL 5 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BENAZEPRIL HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BENAZEPRIL HCL 5 MG TABLET?
BENAZEPRIL HCL 5 MG TABLET (NDC 50268010915) is labeled by AvPAK, and CMS classifies it as a generic product.